Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Ansari

Showing results (111-120 of 195) with videos related to

Pageof 20
Sort By:
Scientific Reports|March 4, 2021
The analysis of GSTA1 promoter genetic and functional diversity of human populationsVid Mlakar, Patricia Huezo-Diaz Curtis, Marc Armengol, et al.
BMC Medical Research Methodology|October 31, 2021
Predictors for participation in DNA self-sampling of childhood cancer survivors in SwitzerlandNicolas Waespe, Sven Strebel, Denis Marino, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 16, 2017
GSTA1 Genetic Variants and Conditioning Regimen: Missing Key Factors in Dosing Guidelines of Busulfan in Pediatric Hematopoietic Stem Cell TransplantationTiago Nava, Mohamed A Rezgui, Chakradhara R S Uppugunduri, et al.
Pediatric Diabetes|February 21, 2014
Diabetes and immune thrombocytopenic purpura: a new association with good response to anti-CD20 therapyLetizia von Laer Tschudin, Valérie M Schwitzgebel, Annette von Scheven-Gête, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 13, 2020
Busulfan Pharmacokinetics in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Gene TherapyKathryn L Bradford, Siyu Liu, Maja Krajinovic, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|February 20, 2024
Brain stem tumors in children less than 3 months: Clinical and radiologic findings of a rare diseaseDanai Papangelopoulou, Brigitte Bison, Lars Behrens, et al.
Bone Marrow Transplantation|April 21, 2023
Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with BusulfanClaire Seydoux, Chakradhara Rao Satyanarayana Uppugunduri, Michael Medinger, et al.
Pediatric Blood & Cancer|June 20, 2022
Severity of hearing loss after platinum chemotherapy in childhood cancer survivorsSven Strebel, Luzius Mader, Tomáš Sláma, et al.
Pediatric Transplantation|December 14, 2011
Third-party mesenchymal stromal cell infusion is associated with a decrease in thrombotic microangiopathy symptoms observed post-hematopoietic stem cell transplantationMarc Ansari, Dirk Strunk, Katharina Schallmoser, et al.
JMIR Research Protocols|May 21, 2025
A Health Service Research Study on a Low-Threshold Hearing Screening Program for Childhood Cancer Survivors in Switzerland: Protocol for the HEAR StudyPhilippa Jörger, Carina Nigg, Luzius Mader, et al.
Pageof 20

Showing results (111-120 of 195) with videos related to

Sort By:
Pageof 20
Scientific Reports|March 4, 2021
The analysis of GSTA1 promoter genetic and functional diversity of human populationsVid Mlakar, Patricia Huezo-Diaz Curtis, Marc Armengol, et al.
BMC Medical Research Methodology|October 31, 2021
Predictors for participation in DNA self-sampling of childhood cancer survivors in SwitzerlandNicolas Waespe, Sven Strebel, Denis Marino, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 16, 2017
GSTA1 Genetic Variants and Conditioning Regimen: Missing Key Factors in Dosing Guidelines of Busulfan in Pediatric Hematopoietic Stem Cell TransplantationTiago Nava, Mohamed A Rezgui, Chakradhara R S Uppugunduri, et al.
Pediatric Diabetes|February 21, 2014
Diabetes and immune thrombocytopenic purpura: a new association with good response to anti-CD20 therapyLetizia von Laer Tschudin, Valérie M Schwitzgebel, Annette von Scheven-Gête, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 13, 2020
Busulfan Pharmacokinetics in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Gene TherapyKathryn L Bradford, Siyu Liu, Maja Krajinovic, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|February 20, 2024
Brain stem tumors in children less than 3 months: Clinical and radiologic findings of a rare diseaseDanai Papangelopoulou, Brigitte Bison, Lars Behrens, et al.
Bone Marrow Transplantation|April 21, 2023
Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with BusulfanClaire Seydoux, Chakradhara Rao Satyanarayana Uppugunduri, Michael Medinger, et al.
Pediatric Blood & Cancer|June 20, 2022
Severity of hearing loss after platinum chemotherapy in childhood cancer survivorsSven Strebel, Luzius Mader, Tomáš Sláma, et al.
Pediatric Transplantation|December 14, 2011
Third-party mesenchymal stromal cell infusion is associated with a decrease in thrombotic microangiopathy symptoms observed post-hematopoietic stem cell transplantationMarc Ansari, Dirk Strunk, Katharina Schallmoser, et al.
JMIR Research Protocols|May 21, 2025
A Health Service Research Study on a Low-Threshold Hearing Screening Program for Childhood Cancer Survivors in Switzerland: Protocol for the HEAR StudyPhilippa Jörger, Carina Nigg, Luzius Mader, et al.
Pageof 20